Prostate cancer / James L. Gulley, guest editor.
- Format:
-
- Contributor:
-
- Series:
-
- Language:
- English
- Subjects (All):
-
- Physical Description:
- 1 online resource (189 p.)
- Place of Publication:
- New York : Demos Medical Publishing, 2011.
- Language Note:
- English
- Summary:
- Emerging Cancer Therapeutics is a trinary, hard cover, periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists who are involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum. With contributions from experts across the United States an
- Contents:
-
- Cover; Half Title; Editors; Title; Copyright; Content; Foreword; Preface; Contributors; Updates in Prostate Cancer Prevention; ABSTRACT; INTRODUCTION; Chemoprevention; PROSTATE CANCER PREVENTION CLINICAL TRIALS; Chemoprevention Agent Development; Trial Endpoints; Study Cohorts; CHEMOPREVENTION CLINICAL TRIAL PROGRAM; The Prostate Cancer Prevention Trial; The Reduction by Dutasteride of Prostate Cancer Events Trial; CONCLUSIONS; REFERENCES; Prostate Cancer Screening, 2011; ABSTRACT; INTRODUCTION; HISTORY OF PSA; SCREENING TRIAL RESULT AND THE RECOMMENDATIONS OFRESPECTED ORGANIZATIONS
- THE PROSPECTIVE RANDOMIZED SCREENING TRIALSOTHER STUDIES DEMONSTRATING THE EFFECTS OF SCREENING; CONCLUSION; REFERENCES; Current Surgical Approaches to Primary Prostate Cancer Treatment; ABSTRACT; INTRODUCTION; OPEN RADICAL RETROPUBIC PROSTATECTOMY (RRP); Surgical Approach to the Open RRP; Outcomes; ROBOTIC-ASSISTED LAPAROSCOPIC PROSTATECTOMY; History of Robotic-Assisted Laparoscopic Prostatectomy; Robot; Surgical Technique of RALP; Learning Curve of RALP; Outcomes; OPEN RRP VERSUS RALP: IS THERE A DIFFERENCE?; Outcomes; CONCLUSIONS; REFERENCES
- Updates in Radiation Therapy for Prostate Cancer: Dose MattersABSTRACT; INTRODUCTION; UPDATES IN IGRT; UPDATES IN BRACHYTHERAPY; Low-Dose Rate Brachytherapy; High-Dose Rate Brachytherapy; Comparisons between EBRT and Brachytherapy; UPDATES IN ADJUVANT/SALVAGE RADIATION THERAPY; Adjuvant Radiation Therapy; Salvage Radiation Therapy; Adjuvant or Salvage Radiation?; CONCLUSION; REFERENCES; An Update on Androgen-Deprivation Therapy for Advanced Prostate Cancer; ABSTRACT; INTRODUCTION; METHODS; MEDICAL ORCHIECTOMY; Gonadotropin-Releasing Hormone Agonists; GnRH Antagonists; ANTIANDROGENS
- COMBINED ANDROGEN BLOCKADETIMING OF ADT; INTERMITTENT ANDROGEN SUPPRESSION; CONCLUSIONS; REFERENCES; Novel Androgen Receptor Therapeutic Targets for Advanced Prostate Cancer; ABSTRACT; INTRODUCTION; MECHANISMS OF CASTRARION RESISTANCE: ANDROGEN PRODUCTION AND AR PATHWAYS; INHIBITION OF ANDROGEN BIOSYNTHESIS; Abiraterone Acetate; Orteronel (TAK-700) and TOK-001; NOVEL AR ANTAGONISTS; MDV3100; Other AR Inhibitors; CONCLUSIONS AND FUTURE DIRECTIONS; ACKNOWLEDGMENTS; REFERENCES; New Understanding of Metabolic Complicationsof Androgen-Deprivation Therapy; ABSTRACT; INTRODUCTION
- ADVERSE EFFECTS OF ADTMetabolic Syndrome; Cardiovascular Risks; Risks for Diabetes; Other Effects of ADT; GUIDELINES ON THE USE AND FOLLOW-UP OF PATIENTS ON ADT; CONCLUSIONS; REFERENCES; Current State of Docetaxel-Based Therapy in Castration-Resistant Prostate Cancer; ABSTRACT; INTRODUCTION; STANDARD DOCETAXEL-BASED COMBINATION; OTHER FIRST-LINE DOCETAXEL-BASED COMBINATIONS; Docetaxel with Antiangiogenic Agents; Docetaxel with Vinorelbine; Docetaxel with Epirubicin; Docetaxel with Capecitabine; Docetaxel with Carboplatin; Docetaxel with Gemcitabine; Docetaxel with Calcitriol
- Docetaxel with Vaccines
- Notes:
- Description based upon print version of record.
- ISBN:
- 1-935281-91-7
- OCLC:
- 781628787
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.